MKGAF
Price
$133.25
Change
+$2.54 (+1.94%)
Updated
Aug 15 closing price
Capitalization
56.5B
PHCUF
Price
$5.87
Change
-$0.13 (-2.17%)
Updated
Aug 7 closing price
Capitalization
161.68M
Interact to see
Advertisement

MKGAF vs PHCUF

Header iconMKGAF vs PHCUF Comparison
Open Charts MKGAF vs PHCUFBanner chart's image
Merck KGaA
Price$133.25
Change+$2.54 (+1.94%)
Volume$330
Capitalization56.5B
Photocure ASA
Price$5.87
Change-$0.13 (-2.17%)
Volume$1K
Capitalization161.68M
MKGAF vs PHCUF Comparison Chart in %
Loading...
MKGAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKGAF vs. PHCUF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKGAF is a Buy and PHCUF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (MKGAF: $133.25 vs. PHCUF: $5.87)
Brand notoriety: MKGAF and PHCUF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MKGAF: 17% vs. PHCUF: 312%
Market capitalization -- MKGAF: $56.5B vs. PHCUF: $161.68M
MKGAF [@Pharmaceuticals: Generic] is valued at $56.5B. PHCUF’s [@Pharmaceuticals: Generic] market capitalization is $161.68M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKGAF’s FA Score shows that 1 FA rating(s) are green whilePHCUF’s FA Score has 1 green FA rating(s).

  • MKGAF’s FA Score: 1 green, 4 red.
  • PHCUF’s FA Score: 1 green, 4 red.
According to our system of comparison, PHCUF is a better buy in the long-term than MKGAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKGAF’s TA Score shows that 5 TA indicator(s) are bullish while PHCUF’s TA Score has 2 bullish TA indicator(s).

  • MKGAF’s TA Score: 5 bullish, 3 bearish.
  • PHCUF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, MKGAF is a better buy in the short-term than PHCUF.

Price Growth

MKGAF (@Pharmaceuticals: Generic) experienced а +8.46% price change this week, while PHCUF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKGAF($56.5B) has a higher market cap than PHCUF($162M). PHCUF has higher P/E ratio than MKGAF: PHCUF (772.72) vs MKGAF (17.26). PHCUF YTD gains are higher at: 4.907 vs. MKGAF (-12.081). MKGAF has higher annual earnings (EBITDA): 6.04B vs. PHCUF (44.5M). MKGAF has more cash in the bank: 1.62B vs. PHCUF (239M). PHCUF has less debt than MKGAF: PHCUF (0) vs MKGAF (8.7B). MKGAF has higher revenues than PHCUF: MKGAF (21.3B) vs PHCUF (523M).
MKGAFPHCUFMKGAF / PHCUF
Capitalization56.5B162M34,877%
EBITDA6.04B44.5M13,578%
Gain YTD-12.0814.907-246%
P/E Ratio17.26772.722%
Revenue21.3B523M4,073%
Total Cash1.62B239M678%
Total Debt8.7B0-
FUNDAMENTALS RATINGS
MKGAF vs PHCUF: Fundamental Ratings
MKGAF
PHCUF
OUTLOOK RATING
1..100
5093
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
7091
PRICE GROWTH RATING
1..100
6145
P/E GROWTH RATING
1..100
916
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKGAF's Valuation (24) in the null industry is significantly better than the same rating for PHCUF (98). This means that MKGAF’s stock grew significantly faster than PHCUF’s over the last 12 months.

MKGAF's Profit vs Risk Rating (91) in the null industry is in the same range as PHCUF (100). This means that MKGAF’s stock grew similarly to PHCUF’s over the last 12 months.

MKGAF's SMR Rating (70) in the null industry is in the same range as PHCUF (91). This means that MKGAF’s stock grew similarly to PHCUF’s over the last 12 months.

PHCUF's Price Growth Rating (45) in the null industry is in the same range as MKGAF (61). This means that PHCUF’s stock grew similarly to MKGAF’s over the last 12 months.

PHCUF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for MKGAF (91). This means that PHCUF’s stock grew significantly faster than MKGAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKGAFPHCUF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
22%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
35%
Momentum
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
24%
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
35%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
30%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
26%
Advances
ODDS (%)
Bullish Trend 3 days ago
59%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
63%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
13%
Aroon
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
MKGAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAK15.000.20
+1.35%
Takeda Pharmaceutical Company Limited
RCKY26.44-0.39
-1.45%
Rocky Brands
TMDX127.55-2.19
-1.69%
TransMedics Group
AMPX7.11-0.33
-4.44%
Amprius Technologies
VCIG0.81-0.04
-5.12%
VCI Global Limited

MKGAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
+1.94%
MKKGY - MKGAF
58%
Loosely correlated
+2.36%
PHCUF - MKGAF
20%
Poorly correlated
N/A
MEDXF - MKGAF
7%
Poorly correlated
+4.22%
OASMY - MKGAF
4%
Poorly correlated
N/A
LBTSF - MKGAF
3%
Poorly correlated
N/A
More

PHCUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHCUF
1D Price
Change %
PHCUF100%
N/A
HLTRF - PHCUF
38%
Loosely correlated
+0.27%
INCR - PHCUF
26%
Poorly correlated
-1.81%
ELAN - PHCUF
24%
Poorly correlated
-0.22%
MKKGY - PHCUF
22%
Poorly correlated
+2.36%
MKGAF - PHCUF
20%
Poorly correlated
+1.94%
More